- Home
- HROW vs DOLE Comparison
HROW vs DOLE Comparison
Compare HROW & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- DOLE
- Stock Information
- Founded
- HROW 1998
- DOLE 1851
- Country
- HROW United States
- DOLE Ireland
- Employees
- HROW N/A
- DOLE N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- DOLE Farming/Seeds/Milling
- Sector
- HROW Health Care
- DOLE Consumer Staples
- Exchange
- HROW Nasdaq
- DOLE Nasdaq
- Market Cap
- HROW 1.4B
- DOLE 1.4B
- IPO Year
- HROW N/A
- DOLE 2021
- Fundamental
- Price
- HROW $43.15
- DOLE $13.58
- Analyst Decision
- HROW Strong Buy
- DOLE
- Analyst Count
- HROW 7
- DOLE 0
- Target Price
- HROW $64.67
- DOLE N/A
- AVG Volume (30 Days)
- HROW 506.9K
- DOLE 1.4M
- Earning Date
- HROW 11-12-2025
- DOLE 11-12-2025
- Dividend Yield
- HROW N/A
- DOLE 2.50%
- EPS Growth
- HROW N/A
- DOLE N/A
- EPS
- HROW N/A
- DOLE 0.25
- Revenue
- HROW $227,661,000.00
- DOLE $8,757,709,000.00
- Revenue This Year
- HROW $45.86
- DOLE $6.69
- Revenue Next Year
- HROW $41.41
- DOLE $1.77
- P/E Ratio
- HROW N/A
- DOLE $53.40
- Revenue Growth
- HROW 47.69
- DOLE 4.75
- 52 Week Low
- HROW $20.85
- DOLE $12.20
- 52 Week High
- HROW $59.23
- DOLE $17.12
- Technical
- Relative Strength Index (RSI)
- HROW 69.90
- DOLE 42.87
- Support Level
- HROW $38.47
- DOLE $13.38
- Resistance Level
- HROW $44.07
- DOLE $14.00
- Average True Range (ATR)
- HROW 1.71
- DOLE 0.29
- MACD
- HROW 0.38
- DOLE -0.06
- Stochastic Oscillator
- HROW 89.11
- DOLE 29.20
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.